Also, CXCL13 plasma concentrations were found to be significantly higher in CLL patients than that in healthy controls and increased with active advanced stage disease, and in those with high risk, which was in line with the prior observation [15, 16]. The gene discussed is CXCL13; the disease is B-cell chronic lymphocytic leukemia.